• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Calcium antagonists: not appropriate as first line antihypertensive agents.

作者信息

Furberg C D, Psaty B M

机构信息

Department of Public Health Sciences, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27157-1063, USA.

出版信息

Am J Hypertens. 1996 Feb;9(2):122-5. doi: 10.1016/0895-7061(96)00014-3.

DOI:10.1016/0895-7061(96)00014-3
PMID:8924261
Abstract
摘要

相似文献

1
Calcium antagonists: not appropriate as first line antihypertensive agents.钙拮抗剂：不宜作为一线抗高血压药物。
Am J Hypertens. 1996 Feb;9(2):122-5. doi: 10.1016/0895-7061(96)00014-3.
2
Calcium channel blockers inferior to cheaper drugs.钙通道阻滞剂比更便宜的药物效果差。
BMJ. 2000 Sep 9;321(7261):590.
3
[German Hypertension League update. What does the ALLHAT Study really mean?].[德国高血压联盟最新消息。ALLHAT研究究竟意味着什么？]
MMW Fortschr Med. 2003 Jun 5;145(23):45-6.
4
Calcium antagonists and cardiovascular events in patients with hypertension and diabetes.
Lancet. 1998 Jan 17;351(9097):216-7. doi: 10.1016/S0140-6736(05)78175-7.
5
An evaluation of cost variation in different brands of antihypertensive agents.
J Assoc Physicians India. 1998 Jun;46(6):573-4.
6
Calcium antagonists should continue to be used for first-line treatment of hypertension.钙拮抗剂应继续用于高血压的一线治疗。
Arch Intern Med. 1995 Nov 13;155(20):2150-6.
7
Calcium channel blockers. Consensus amid controversy.钙通道阻滞剂。争议中的共识。
Postgrad Med. 1997 Dec;102(6):127-8, 133-6. doi: 10.3810/pgm.1997.12.385.
8
[Calcium channel blockers and cardiovascular morbidity mortality].[钙通道阻滞剂与心血管发病率及死亡率]
An Med Interna. 1997 May;14(5):217-9.
9
[New perspectives. Pharmacological approach to arterial hypertension].
Aten Primaria. 1992 May;9(7):380-3, 386-7.
10
Cardiovascular outcomes and antihypertensive drug treatment in older women.老年女性的心血管结局与降压药物治疗
JAMA. 2005 Apr 6;293(13):1588; author reply 1588-9. doi: 10.1001/jama.293.13.1588-a.

引用本文的文献

1
Differential effects of urapidil and doxazosin on heart rate.
Eur J Clin Pharmacol. 2007 Mar;63(3):259-62. doi: 10.1007/s00228-006-0256-2. Epub 2007 Jan 16.
2
Has the role of calcium channel blockers in treating hypertension finally been defined?
Curr Hypertens Rep. 2003 Aug;5(4):295-300. doi: 10.1007/s11906-003-0037-6.
3
The use of calcium antagonists in the treatment of hypertensive persons with kidney disease.
Curr Hypertens Rep. 2002 Jun;4(3):191-4. doi: 10.1007/s11906-002-0006-5.
4
Manidipine: a review of its use in hypertension.马尼地平：其在高血压治疗中的应用综述
Drugs. 2001;61(12):1777-99. doi: 10.2165/00003495-200161120-00010.
5
Role of a third generation calcium antagonist in the management of hypertension.第三代钙拮抗剂在高血压治疗中的作用。
Drugs. 1999;57 Suppl 1:1-10. doi: 10.2165/00003495-199957001-00001.
6
Safety and tolerability of moxonidine in the treatment of hypertension.莫索尼定治疗高血压的安全性和耐受性。
Drug Saf. 1998 Sep;19(3):191-203. doi: 10.2165/00002018-199819030-00003.
7
Should calcium antagonists be first-line agents in the treatment of cardiovascular disease? The public health perspective.
Cardiovasc Drugs Ther. 1996 Sep;10(4):463-6. doi: 10.1007/BF00051111.
8
1,4-Dihydropyridines versus beta-blockers for hypertension: are either safe for the heart?1,4 - 二氢吡啶类药物与β受体阻滞剂治疗高血压：对心脏而言二者都安全吗？
Cardiovasc Drugs Ther. 1996 Sep;10(4):397-402. doi: 10.1007/BF00051102.